Nolvadex has the followingFDA Boxed Warning: Serious and life-threatening events, including uterine malignancies, stroke, and blood clots in the lungs, can occur in women with DCIS and in women who are at high risk for breast cancer., Before you start treatment with Nolvadex, be sure to tell your healthcare provider about:, All the medications you take, Your allergies, Your health history and current health problems, Your pregnancy or breastfeeding status, Endometrial changes have been reported with Nolvadex treatment., Nolvadex can increase the risk of blood clots., Liver changes have occurred with Nolvadex treatment., Second primary tumors have been reported with Nolvadex treatment., Vision problems and eye changes have been reported with Nolvadex treatment., Nolvadex can cause harm to an unborn baby. Women of child-bearing age should avoid becoming pregnant while being treated with Nolvadex and within 2 months of stopping Nolvadex. Effective barrier or non-hormonal birth control measures should be used. All the medications you take, Your allergies, Your health history and current health problems, Your pregnancy or breastfeeding status
